We serve Chemical Name:1-(Benzyloxy)-4-bromo-2-chlorobenzene CAS:56872-27-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(Benzyloxy)-4-bromo-2-chlorobenzene
CAS.NO:56872-27-6
Synonyms:4-bromo-2-chloro-1-phenylmethoxybenzene
Molecular Formula:C13H10BrClO
Molecular Weight:297.57500
HS Code:2909309090
Physical and Chemical Properties:
Melting point:58-62ºC
Boiling point:366.808ºC at 760 mmHg
Density:1.471g/cm3
Index of Refraction:1.609
PSA:9.23000
Exact Mass:295.96000
LogP:4.68150
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3077 9/PG 3
Packing Group:
Contact us for information like 4-bromo-2-chloro-1-phenylmethoxybenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-bromo-2-chloro-1-phenylmethoxybenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-bromo-2-chloro-1-phenylmethoxybenzene Use and application,4-bromo-2-chloro-1-phenylmethoxybenzene technical grade,usp/ep/jp grade.
Related News: Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API. 1-(Benzyloxy)-4-bromo-2-chlorobenzene manufacturer The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application. 1-(Benzyloxy)-4-bromo-2-chlorobenzene supplier Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API. 1-(Benzyloxy)-4-bromo-2-chlorobenzene vendor Physiologically relevant interactions with test molecules or protein ligands can be identified with high sensitivity and specificity. 1-(Benzyloxy)-4-bromo-2-chlorobenzene factory The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.
